Skinlumis is building the first longitudinal skin outcome dataset built on standardized imaging, structured check-ins, and archetype-level cohort tracking. Early partners shape the methodology.
See which outcomes track with which skin archetypes, grounded in standardized measurement rather than self-report.
Observe how specific ingredients perform across real, longitudinal use, not a single-panel snapshot.
Segment outcomes by life stage, so hormonal, menopausal, and stress-driven skin are analyzed distinctly.
Follow skin as it changes over time, across seasons, protocols, and life events, not just before and after.
We are in our founding dataset phase.
Early partners receive methodology access, preliminary cohort previews, and research co-authorship rights.
Pricing reflects the current data maturity stage.
The founding dataset phase. Early partners shape methodology as the first standardized records are built.
With 10,000+ longitudinal scans, cohort patterns become statistically meaningful across archetypes and life stages.
At 100,000+ scans, the dataset supports category-level intelligence and predictive outcome modeling.
Shape the methodology from the founding phase.